Sun Pharma Q2 profit rises 15%, lags estimates

Sun Pharmaceutical Industries Ltd, India's largest drugmaker by revenue, reported a 15 per cent jump in second-quarter net profit on Thursday, but slightly lagged estimates.

Net income for the quarter ended September was Rs 1,572 crore ($255.4 million), up from Rs 1,362 crore a year earlier. Analysts on average expected net income of Rs 1,588 crore, according to Thomson Reuters I/B/E/S.

Sun Pharma , which is in the process of acquiring rival drugmaker Ranbaxy Laboratories Ltd, is awaiting approval from India's antitrust regulator for the deal.

(1 US dollar = Rs 61.5600 rupee)

(Reuters)